NCT01240577
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,998 public trials
2,034 recruiting studies
Immunoproliferative Disorders trial results
NCT00896454
- Conditions
- Blood Protein Disorders, Breast Cancer, Breast Diseases, +77 more
- Locations
-
- Research Site Encinitas, California, United States
- Research Site New Haven, Connecticut, United States
- Research Site Salisbury, Maryland, United States
- Research Site Dearborn, Michigan, United States
NCT01342289
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +22 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
NCT03000452
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- Cancer Center of Central Connecticut Southington, Connecticut, United States
- Parkview Research Center Fort Wayne, Indiana, United States
- Indiana University Cancer Center Indianapolis, Indiana, United States
NCT02264873
- Conditions
- Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +19 more
- Locations
-
- UF Health Shands Hospital Gainesville, Florida, United States
NCT01687179
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Completed
Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
NCT00231166
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Dana Farber Cancer Institute StudyCoordinator:CHCD122A2102 Boston, Massachusetts, United States
- St. Vincent's Comprehensive Cancer Center Dept. of St. Vincent's Cancer New York, United States
- Oregon Health Sciences University Portland, Oregon, United States
- University of Pennsylvania--Abramson Cancer Center StudyCoordinator:CHCD122A2102 Philadelphia, Pennsylvania, United States
NCT02669615
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT01719250
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01178086
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann Frechen, Germany